Keyphrases
Tumor
100%
Conditioned Medium
100%
Chemoresistance
100%
Soluble Factors
100%
Ovarian Cancer Cells
100%
Mesenchymal Stromal Cells
100%
Platinum Sensitivity
37%
Tumor Microenvironment
25%
Ovarian Cancer
25%
Preadipocytes
25%
Cancer Cells
12%
FDA-approved Drugs
12%
Standard of Care
12%
Interleukin-6
12%
Most Common Form
12%
Chemosensitivity
12%
Combination Therapy
12%
Survival Rate
12%
Poor Survival
12%
Ovarian Cancer Patients
12%
Acquired Resistance
12%
Stromal Cells
12%
Advanced Stage
12%
Platinum-based Chemotherapy
12%
Gynecologic Malignancies
12%
Hepatocyte Growth Factor
12%
Carboplatin
12%
Platinum Resistance
12%
Durable Response
12%
Adipocyte Cell
12%
Crizotinib
12%
Resistance to Therapy
12%
3T3-L1
12%
Media Content
12%
Variable Sensitivity
12%
Toxicity Resistance
12%
Media Activity
12%
JAK Inhibitors
12%
Soluble uPAR
12%
MET Inhibitor
12%
Medicine and Dentistry
Mesenchymal Stem Cell
100%
Cancer Cell
100%
Neoplasm
100%
Drug Resistance
100%
Ovarian Cancer
100%
Adipocyte
20%
Tumor Microenvironment
20%
Cancer
10%
Chemosensitivity
10%
Combination Therapy
10%
Survival Rate
10%
Interleukin-6
10%
Stromal Cell
10%
Carboplatin
10%
Ovarian Cancer Cell Line
10%
Scatter Factor
10%
Hepatocyte Growth Factor
10%
Crizotinib
10%
3T3-L1
10%
Janus Kinase Inhibitor
10%